Topline results from the company’s Phase III trial showed a statistically significant improvement in the time patients took to recover after getting the drug for five days, but data for the 10-day regimen did not reach statistical significance despite also showing an improvement.

LEAVE A REPLY

Please enter your comment!
Please enter your name here